Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiagCor Bioscience is a Hong Kong-based biotechnology company specializing in molecular diagnostics (MDx) and specialized laboratory services. Founded in 2006 by Dr. Joseph Wing-On Tam, the company is a pioneer in flow-through hybridization technology, which enables rapid and cost-effective DNA testing. Their flagship platform, the FT-PRO system, supports a wide range of GenoFlow diagnostic kits for detecting HPV, tuberculosis, and various respiratory and hereditary diseases. DiagCor operates a CAP-accredited laboratory providing clinical testing and contract research services to global healthcare providers. The company focuses on translating genomic research into accessible diagnostic tools for personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DiagCor Bioscience.